Myeloperoxidase Alters Lung Cancer Cell Function to Benefit Their Survival

Area of Science:

• Biochemistry
• Cell Biology
• Oncology

Background:

• Myeloperoxidase (MPO), an enzyme from neutrophils, is linked to tumor development.
• The precise mechanisms of MPO's role in cancer progression are not fully understood.

Purpose of the Study:

• To investigate the functional impact of MPO on A549 human lung cancer cells.
• To explore the mechanisms underlying MPO's effects on cancer cell behavior and potential therapeutic targets.

Main Methods:

• Assessed MPO's effects on A549 cell proliferation, apoptosis, and signaling pathways (AKT, ERK).
• Investigated MPO binding, internalization, and subcellular localization (including nuclear translocation).
• Utilized heparin to block MPO uptake and 4-aminobenzoic acid hydrazide (4-ABAH) to inhibit MPO activity in vitro and in vivo.

Main Results:

• MPO enhanced A549 cell proliferation and suppressed apoptosis, increasing AKT and ERK phosphorylation.
• MPO was internalized by A549 cells, retained activity, and translocated to the nucleus.
• Blocking MPO uptake or inhibiting its enzymatic activity with 4-ABAH counteracted MPO's pro-cancer effects.
• Treatment with 4-ABAH significantly reduced tumor burden in mice.

Conclusions:

• Myeloperoxidase significantly influences lung cancer cell function, promoting proliferation and survival.
• MPO's enzymatic activity and cellular uptake are critical for its oncogenic effects.
• Inhibiting MPO represents a potential therapeutic strategy for reducing lung cancer progression.